XK469, a selective topoisomerase IIβ poison

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 21, 1999, Pages 12168-12173

  Gao, Hanlin ^a   Huang, Kuan Chun ^a   Yamasaki, Edith F ^a   Chan, Kenneth K ^a,b   Chohan, Lubna ^a   Snapka, Robert M ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); UNCLASSIFIED DRUG; XK 469;

ANIMAL CELL; ARTICLE; CROSS LINKING; DRUG ACTIVITY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; ENZYME MECHANISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; SOLID TUMOR;

ANIMALS; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE; CENTRIFUGATION, DENSITY GRADIENT; CERCOPITHECUS AETHIOPS; CROSS-LINKING REAGENTS; DNA; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; FIBROBLASTS; HUMANS; ISOENZYMES; QUINOXALINES; SUBSTRATE SPECIFICITY;

EID: 0032742699     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.21.12168     Document Type: Article

References (28)

1. Corbett, T. H., LoRusso, P., Demchick, L., Simpson, C., Pugh, S., White, K., Küshner, J., Polin, L., Meyer, J., Czarnecki, J., et al. (1998) Invest. New Drugs 16, 129-139.
2. LoRusso, P. M., Demchick, L., Knight, J., Polin, L., Behrens, C. H., McRipley, R., Gross', J. L., Harrison, B. A. & Corbett, T. H. (1994) Proc. Am. Assoc. Cancer Res. 35, 401 (abstr.).
3. Valeriote, F., Corbett, T., Edelstein, M. & Baker, L. (1996) Clin. Sci. Res. 14, 124-141.
4. Valeriote, F., Moore, R. E., Patterson, G. M. L., Paul, V. J., Scheurer P. J. & Corbett, T. (1991) in Anticancer Drug Discovery and Development: Natural Products and New Molecular Models, eds. Valeriote, F. A., Corbett, T. H. & Baker, L. H. (Kluwer, Boston), pp. 2-25.
5. Subramanin, B., Nakeff, A. & Valeriote, F. V. (1999) Proc. Am. Assoc. Cancer. Res. 40, 1 (abstr.).
6. Austin, C. A. & Marsh, K. L. (1998) BioEssays 20, 215-226.
7. Kaufmann, S. H., McLaughlin, S. J., Kastan, M. B., Liu, L. F., Karp, J. E. & Burke, P. J. (1991) Cancer Res. 51, 3534-3543.
8. Drake, F. H., Hofmann, G. A., Bartus, H. F., Mattern, M. R., Crooke, S. T. & Mirabelli, C. K. (1989) Biochemistry 28, 8154-8160.
9. Kimura K., Saijo, M., Ui, M. & Enomoto, T. (1994) J. Biol. Chem. 269, 1173-1176.
10. Negri, C., Chiesa R., Cerino, A., Bestagno, M., Sala, C., Zini, N Maraldi, N. M. & Astaldi Ricotti, G. C. B. (1992) Exp. Cell Res. 200, 452-459.
11. Brown, G. A., McPherson, J. P., Gu, L., Hedley, D. W., Toso, R., Deuchars, K. L. Freedman, M. H. & Goldenberg, G. J. (1995) Cancer Res. 55, 78-82.
12. Cornarotti, M., Tinelli, S., Willmore, E., Zuninio, F., Fisher, L. M., Austin, C. A. & Capranico, G. (1996) Mol. Pharmacol. 50, 1463-1471.
13. Harker, W. G., Slade, D. L., Drake, F. H. & Parr, R. L. (1991) Biochemistry 30, 9953-9961.
14. Perrin, D., Van Hille, B. & Hill, B. T. (1998) Biochem. Pharmacol. 56, 503-507.
15. Shin, C.-G., Strayer, J. M., Wani, M. A. & Snapka, R. M. (1990) Teratog. Carcinog. Mutagen. 10, 41-52.
16. Woo, S. H., Reynolds, M. C., Sun, N. J., Cassady, J. M. & Snapka, R. M. (1997) Biochem. Pharmacol. 54, 467-473.
17. Hirt, B. (1967) J. Mol. Biol. 26, 365-369.
18. Rosenstein, B. S., Subramanian, D. & Muller, M. T. (1997) Radiat. Res. 148, 575-579.
19. Laemmli, U. K. (1970) Nature (London) 227, 680-685.
20. Fortune, J. M. & Osheroff, N. (1998) J. Biol. Chem. 273, 17643-17650.
21. Nitiss, J. L. & Beck, W. T. (1996) Eur. J. Cancer 32A, 958-966.
22. Prost, S. (1995) Gen. Pharmacol. 26, 1773-1784.
23. Herzog, C. E., Holmes, K. A., Tuschong, L. M., Ganapathi, R. & Zwelling, L. A. (1998) Cancer Res. 58, 5298-5300.
24. Withoff, S., De Vries, E. G. E., Keith, W. N., Nienhuis, E. F., van der Graaf, W. T. A., Uges, D. R. A. & Mulder, N. H. (1996) Br. J. Cancer 74, 1869-1876.
25. Dereuddre, S., Delaporte, C. & Jacquemin-Sablon, A. (1997) Cancer Res. 57, 4301-4308.
26. Hsiang, Y.-H. & Liu, L. F. (1988) Cancer Res. 48, 1722-1726.
27. Sorensen, M., Sehested, M. & Jensen, P. B. (1999) Mol. Pharmacol. 55, 424-431.
28. Pilot, H. C. (1986) in Fundamentals of Oncology (Dekker, New York), pp. 449-471.